Jim Simons Dynavax Technologies Corp Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,314,278 shares of DVAX stock, worth $29.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,314,278

Previous 2,478,178 6.61%

Holding current value

$29.4 Million

Previous $27.8 Million 7.36%

% of portfolio

0.04%

Previous 0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$10.05 - $11.61 $1.65 Million - $1.9 Million	-163,900 Reduced 6.61%	2,314,278 $25.8 Million
Q2 2024 Aug 09, 2024	BUY	$10.73 - $12.58 $575,128 - $674,288	53,600 Added 2.21%	2,478,178 $27.8 Million
Q1 2024 May 13, 2024	BUY	$11.7 - $14.98 $5.69 Million - $7.29 Million	486,500 Added 25.1%	2,424,578 $30.1 Million
Q4 2023 Feb 13, 2024	BUY	$13.09 - $14.98 $3.97 Million - $4.54 Million	303,049 Added 18.53%	1,938,078 $27.1 Million
Q3 2023 Nov 14, 2023	SELL	$12.64 - $14.99 $4.32 Million - $5.12 Million	-341,703 Reduced 17.29%	1,635,029 $24.1 Million
Q2 2023 Aug 11, 2023	SELL	$9.85 - $13.17 $6.6 Million - $8.82 Million	-669,577 Reduced 25.3%	1,976,732 $25.5 Million
Q1 2023 May 12, 2023	BUY	$9.44 - $11.88 $9.78 Million - $12.3 Million	1,035,658 Added 64.3%	2,646,309 $26 Million
Q4 2022 Feb 13, 2023	BUY	$10.27 - $13.29 $5.6 Million - $7.25 Million	545,300 Added 51.19%	1,610,651 $17.1 Million
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $1.84 Million - $3.24 Million	-185,500 Reduced 14.83%	1,065,351 $11.1 Million
Q2 2022 Aug 12, 2022	BUY	$7.45 - $12.83 $4.69 Million - $8.07 Million	629,200 Added 101.21%	1,250,851 $15.7 Million
Q1 2022 May 13, 2022	BUY	$9.75 - $14.44 $3.65 Million - $5.4 Million	374,100 Added 151.12%	621,651 $6.74 Million
Q4 2021 Feb 11, 2022	SELL	$13.17 - $20.94 $2.87 Million - $4.56 Million	-217,554 Reduced 46.78%	247,551 $3.48 Million
Q3 2021 Nov 12, 2021	BUY	$9.16 - $19.83 $4.26 Million - $9.22 Million	465,105 New	465,105 $8.94 Million
Q3 2019 Nov 13, 2019	SELL	$2.69 - $4.85 $503,705 - $908,167	-187,251 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$3.65 - $7.89 $683,466 - $1.48 Million	187,251 New	187,251 $747,000

Others Institutions Holding DVAX

# of Institutions

275

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.61B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account